Prof. Gustavo Duque, MD, Ph.D., FRACP, FGSA, Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, 176 Furlong Road, St. Albans, VIC, Australia 3121, Tel: +61 3 8395 8121, E-mail:
J Nutr Health Aging. 2021;25(1):25-32. doi: 10.1007/s12603-020-1537-7.
Osteosarcopenia is a geriatric syndrome defined by the concomitant presence of osteopenia/osteoporosis (loss of bone mineral density (BMD)) and sarcopenia (loss of muscle mass and/or function), which increases the risk of falls, fractures, and premature mortality.
To examine the efficacy of non-pharmacological (exercise and/or nutritional) interventions on musculoskeletal measures and outcomes in osteosarcopenic adults by reviewing findings from randomized controlled trials (RCTs).
This review was registered at PROSPERO (registration number: CRD42020179292) and conducted in accordance with the PRISMA guidelines. Electronic databases were searched for RCTs assessing the effect of at least one non-pharmacological intervention (any form of exercise and/or supplementation with protein, vitamin D, calcium or creatine) on any musculoskeletal measure/outcome of interest (BMD, bone strength/turnover, muscle mass and strength, physical performance, falls/fractures) in adults with osteosarcopenia as defined by any proposed criteria.
Two RCTs (of n=106 older osteosarcopenic adults (≥65 years)) assessing the effects of progressive resistance training (RT) (via resistance bands or machines; 2-3 times/week; ~60 minutes in duration) were eligible for inclusion. The two RCTs demonstrated moderate quality evidence that RT increases muscle mass, strength, and quality, with changes in strength and quality occurring before muscle mass (12 vs 28 weeks). There was low quality evidence that RT increases lumbar spine BMD and maintains total hip BMD when performed for 12 and 18 months, respectively, and moderate quality evidence that RT has no effect on markers of bone turnover or physical performance. No major adverse effects were recorded in either of the RCTs. There were no eligible RCTs examining the impact of nutritional interventions.
Chronic RT is safe and effective at potentiating gains in muscle mass, strength, and quality, and increasing or maintaining BMD in older osteosarcopenic adults. No RCT has examined the effects of protein, vitamin D, calcium, or creatine against a control/placebo in this high-risk population.
骨质疏松-肌少症是一种老年综合征,其特征是同时存在骨量减少/骨质疏松症(骨矿物质密度降低)和肌少症(肌肉质量和/或功能丧失),这会增加跌倒、骨折和早逝的风险。
通过回顾随机对照试验(RCT)的结果,研究非药物干预(运动和/或营养)对骨质疏松-肌少症成年人骨骼肌肉测量指标和结果的疗效。
本研究已在 PROSPERO(注册号:CRD42020179292)上注册,并按照 PRISMA 指南进行。电子数据库检索评估至少一种非药物干预(任何形式的运动和/或补充蛋白质、维生素 D、钙或肌酸)对任何骨骼肌肉测量指标/结果(骨密度、骨强度/转换、肌肉质量和力量、身体表现、跌倒/骨折)的影响的 RCT,这些 RCT 纳入的对象为符合任何提出的标准的骨质疏松-肌少症成年人。
两项 RCT(共纳入 106 名年龄较大的骨质疏松-肌少症成年人(≥65 岁))评估了渐进式抗阻训练(RT)(通过阻力带或机器进行;每周 2-3 次;每次约 60 分钟)的效果。这两项 RCT 提供了中等质量的证据,表明 RT 可增加肌肉质量、力量和质量,且力量和质量的变化先于肌肉质量(12 周与 28 周)。低质量证据表明,分别进行 12 个月和 18 个月的 RT 可增加腰椎骨密度和维持全髋骨密度,而中等质量证据表明 RT 对骨转换标志物或身体表现没有影响。在这两项 RCT 中均未记录到重大不良事件。没有纳入评估营养干预影响的 RCT。
慢性 RT 安全且有效,可促进老年骨质疏松-肌少症成年人肌肉质量、力量和质量的增加,并增加或维持骨密度。在这个高风险人群中,没有 RCT 研究蛋白质、维生素 D、钙或肌酸与对照/安慰剂的效果。